Results 1 to 10 of about 1,587,729 (380)

Head and Neck Cancer

open access: yesCancer chemotherapy and biological response modifiers, 1991
Cisplatin has been an important addition to the treatment of head and neck cancer. It is the only drug to have been proven to cause a survival benefit when compared with supportive care alone in the palliative management of advanced head and neck cancer (Morton et al. 1985).
Samuel G. Taylor, Katherine Griem
openaire   +13 more sources

Head and neck squamous cell carcinoma

open access: yesNature Reviews Disease Primers, 2020
Most head and neck cancers are derived from the mucosal epithelium in the oral cavity, pharynx and larynx and are known collectively as head and neck squamous cell carcinoma (HNSCC).
Daniel E. Johnson   +5 more
semanticscholar   +2 more sources

Contents Vol. 33 no. 1 January– June 2018

open access: yesPhilippine Journal of Otolaryngology Head and Neck Surgery, 2020
EDITORIAL 4 Peer Review and the PJOHNS: Principles, Problems and Promise Lapeña JF ORIGINAL ARTICLES 6 Endoscopic Sinus Surgery Perioperative Outcomes after Intravenous Tranexamic Acid: A Double Blind Randomized Controlled Trial Quiroga ...
Philipp J Otolaryngol Head and Neck Surg
doaj   +1 more source

Contents Vol. 34 no. 1 January – June 2019

open access: yesPhilippine Journal of Otolaryngology Head and Neck Surgery, 2020
EDITORIAL 4 Authorship Controversies: Gift, Guest and Ghost Authorship Lapeña JF META-ANALYSIS 6 Morbidity Outcomes of Prophylactic Central Neck Dissection with Total Thyroidectomy versus Total Thyroidectomy Alone in Patients with Node ...
Philipp J Otolaryngol Head and Neck Surg
doaj   +1 more source

Angiosarcoma of the Head and Neck [PDF]

open access: yesInternational Archives of Otorhinolaryngology, 2015
Introduction Angiosarcoma of the head and neck is a rare vascular sarcoma associated with high rates of local recurrence and distant metastasis and a poor prognosis. Objective We describe our experience treating patients with angiosarcoma of the head and neck to evaluate the outcomes, patterns of failure, and current treatments.
Mullins, Brandon, Hackman, Trevor
openaire   +6 more sources

NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.

open access: yesThe Journal of the National Comprehensive Cancer Network, 2022
The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer, salivary gland cancer, and mucosal melanoma (MM) are also addressed.
J. Caudell   +36 more
semanticscholar   +1 more source

Contents Vol. 33 no. 2 July – December 2018

open access: yesPhilippine Journal of Otolaryngology Head and Neck Surgery, 2020
EDITORIAL 4 A Dozen Years, A Dozen Roses Lapeña JF ORIGINAL ARTICLES 6 Efficacy of Clarithromycin Versus Methylprednisolone in the Treatment of Non-Eosinophilic and Eosinophilic Nasal Polyposis: A Randomized Controlled Trial Gammad JC ...
Philipp J Otolaryngol Head and Neck Surg
doaj   +1 more source

Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors

open access: yesBritish Dental Journal, 2022
Introduction Head and neck cancer appears to be increasing in incidence, with potential changes in aetiology proposed. This paper aims to provide a narrative overview of the epidemiological literature to describe the disease burden and trends in terms of
M. Gormley   +4 more
semanticscholar   +1 more source

Contents Vol. 32 no. 1 January – June 2017

open access: yesPhilippine Journal of Otolaryngology Head and Neck Surgery, 2020
EDITORIAL 4 Hubris, Humility and Healing Lapeña JF ORIGINAL ARTICLES 6 Low Frequency Ultrasound in Chronic Rhinosinusitis with Nasal Polyposis and Recovery after Endoscopic Sinus Surgery: A Randomized Controlled Trial De Castro RB, Cruz ...
Philipp J Otolaryngol Head and Neck Surg
doaj   +1 more source

Home - About - Disclaimer - Privacy